25 May 2013
Keywords: summit, evolva, deal, smt, corp, uk, drug
Article | 12 January 2009
Summit Corp, a UK drug discovery company, has entered into an exclusive worldwide licensing agreement with the Swiss company, Evolva ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 January 2009
24 May 2013
© 2013 thepharmaletter.com